
Welcome to
ONLiNE UPSC
Tirzepatide is an innovative medication developed to manage type 2 diabetes and obesity effectively. It functions as a dual agonist for both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.
Tirzepatide mimics the actions of GIP and GLP-1 hormones, which are crucial for regulating blood sugar levels and appetite. By activating these receptors, tirzepatide provides several key benefits:
Multiple studies, including the SURPASS trials, have validated the effectiveness of tirzepatide in reducing HbA1c levels and supporting weight loss in patients with type 2 diabetes:
Tirzepatide is delivered through a subcutaneous injection once a week. The dosage can be tailored to meet individual patient requirements and tolerability.
Tirzepatide stands as a significant advancement in treating type 2 diabetes and obesity. Its dual-action mechanism provides comprehensive benefits in blood sugar management and weight loss, making it an encouraging option for those seeking improved metabolic health.
Q1. What is the primary function of Tirzepatide?
Answer: Tirzepatide primarily functions to manage type 2 diabetes and obesity by mimicking hormones that regulate blood sugar and appetite.
Q2. How is Tirzepatide administered?
Answer: Tirzepatide is administered via a subcutaneous injection once a week, with dosage adjusted based on patient needs.
Q3. What are the common side effects of Tirzepatide?
Answer: Common side effects include gastrointestinal issues like nausea and diarrhea, and there is a risk of hypoglycemia when combined with other diabetes medications.
Q4. What evidence supports the effectiveness of Tirzepatide?
Answer: Clinical trials such as the SURPASS series demonstrate Tirzepatide's effectiveness in lowering HbA1c levels and promoting significant weight loss.
Q5. How does Tirzepatide compare to other diabetes medications?
Answer: Studies indicate that Tirzepatide shows superior outcomes in glycemic control and weight loss compared to other GLP-1 receptor agonists like semaglutide.
Question 1: What is Tirzepatide primarily used for?
A) Managing type 1 diabetes
B) Managing type 2 diabetes and obesity
C) Treating cardiovascular diseases
D) Curing diabetes
Correct Answer: B
Question 2: How often is Tirzepatide administered?
A) Daily
B) Bi-weekly
C) Weekly
D) Monthly
Correct Answer: C
Question 3: Which trial series evaluated Tirzepatide's efficacy?
A) TRIAL-1
B) SURPASS Trials
C) TEST-2
D) STUDY-3
Correct Answer: B
Question 4: What is a common side effect of Tirzepatide?
A) Hair loss
B) Nausea
C) Insomnia
D) Skin rash
Correct Answer: B
Question 5: What effect does Tirzepatide have on appetite?
A) Increases appetite
B) No effect
C) Decreases appetite
D) Causes cravings
Correct Answer: C
Kutos : AI Assistant!